Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response

Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response
复制标题

DOI:
10.1038/70265
复制
发表时间:
1999-12-01
影响因子:
21.3
通讯作者:
Tohyama, M
Tohyama, M
中科院分区:
生物学1区
文献类型:
--
作者:
Katayama, T;Imaizumi, K;Tohyama, M

文献摘要

被引文献

相似文献

发现于14号染色体上的人类早老素-1(PSI)基因中的错义突变导致早发性家族性阿尔茨海默病(FAD),FAD连锁的PSI变体改变淀粉样前体蛋白的蛋白水解加工并导致各种细胞应激诱导的细胞凋亡的脆弱性增加,然而,负责这些现象的机制尚不清楚,在这里,我们报告说,PSI的突变影响未折叠蛋白反应(UPR),这响应于在内质网(ER)中积累的未折叠蛋白的量增加的条件下,导致ER应激。PSI突变还导致GRP 78/Bip的表达降低,GRP 78/Bip是一种存在于ER中的分子伴侣,可以使蛋白质折叠。有趣的是,GRP 78水平在阿尔茨海默病患者的脑中降低。PSI突变引起的UPR信号传导的下调是由IRE 1的功能紊乱引起的,IRE 1是ER腔中状况的近端传感器。在携带PS1突变体的神经母细胞瘤细胞中GRP 78的过表达几乎完全将对ER应激的抗性恢复到表达野生型PS1的细胞的水平,这些结果表明,PS1的突变可能会通过改变UPR信号通路增加对ER应激的脆弱性。
Missense mutations in the human presenilin-1 (PSI) gene, which is found on chromosome 14, cause early-onset familial Alzheimer's disease (FAD), FAD-linked PSI variants alter proteolytic processing of the amyloid precursor protein and cause an increase in vulnerability to apoptosis induced by various cell stresses, However, the mechanisms responsible for these phenomena are not clear, Here we report that mutations in PSI affect the unfolded-protein response (UPR), which responds to the increased amount of unfolded proteins that accumulate in the endoplasmic reticulum (ER) under conditions that cause ER stress. PSI mutations also lead to decreased expression of GRP78/Bip, a molecular chaperone, present in the ER, that can enable protein folding. Interestingly, GRP78 levels are reduced in the brains of Alzheimer's disease patients, The downregulation of UPR signalling by PSI mutations is caused by disturbed function of IRE1, which is the proximal sensor of conditions in the ER lumen, Overexpression of GRP78 in neuroblastoma cells bearing PS1 mutants almost completely restores resistance to ER stress to the level of cells expressing wild-type PS1, These results show that mutations in PS1 may increase vulnerability to ER stress by altering the UPR signalling pathway.